The CheqUp approach to weight management
The opportunity
The CheqUp approach to weight management
Our method
Obesity is a lifelong chronic disease affecting some 14 million people in the UK which costs the NHS £6.1 billion per year. It is a debilitating condition associated with a range of co-morbidities such as type 2 diabetes, certain cancers, hypertension, heart problems and so on.
The emergence of life-changing medications, Tirzepatide and Wegovy, presents a once-in-a-lifetime opportunity to combat obesity - as clinical trials show weight loss in 16-18 months of 26% and 15% respectively, These belong to a class of drugs called GLP-1 receptor agonists. This is because they mimic the action of glucagon-like peptide-1, a natural hormone in the body which manages hunger. Their primary mechanism revolves around suppressing hunger and promoting a sense of fullness, leading to reduced food intake.
As part of their action, GLP-1 medications slow down the emptying of the stomach, helping individuals to feel satisfied for longer, and they act on the brain to dampen cravings and the desire to eat, creating a dual effect that helps weight loss.
Medications like Mounjaro and Wegovy were never designed to be taken in isolation. Both medicines mimic the hormone that tells us we are full, helping to reduce our food consumption and losing weight over the course of many months (please see our blog on the wider health benefits of weight loss injections by clicking here) But that can have physical and psychological results which need careful management; and simply taking the drug on its own isn’t enough to deliver sustained weight loss. For that, patients need to effect long-term changes in their diet and their approach to physical exercise. All of these elements need to be brought together for the medicines to work effectively.
That’s why CheqUp offers a full weight management service to accompany the medication, consisting of diet support, physical activity advice, psychological counselling where necessary, nurses, health coaches and, of course, specialist obesity doctors. All our interactions are designed and led by experts - with virtual contact facilitated through our web platform.
We encourage all patients to embark on a long-term weight loss journey. The flexible program includes regular virtual appointments with obesity specialists, dieticians, physical activity advisors, nurses, and health coaches. While you’re losing weight, our clinicians constantly assess your progress to provide a comprehensive and individualised approach to weight management. We understand that these medications can bring up a lot of questions, so we encourage all our clients to email us at help@chequp.com with any questions, to arrange check-ins with your health coach or to book an appointment with one of our specialist clinicians.
We believe that this is by far the most effective way to lose weight - it mirrors the way the clinical trials for Mounjaro and Wegovy were structured and the approach the NHS uses in its hospitals. This approach has been proven to get the best out of the medications - to provide initial assistance on how to take weight loss injections, to manage the common side-effects, to help with the dose increase (“titration”) stage. In short - to hold your hand on every step of your journey.
A long-term weight loss programme is an investment of time, effort, emotion and money.
A weight loss journey takes many months, even years, so it is worth spending this time productively and not wasting your precious time on yet another fad diet. We know that dieting takes real effort - it can be really hard to resist the “food noise” and deal with the hunger and the cravings, so make the effort count. Diets can be emotionally draining - we all have bad days when the scales just aren't shifting or everyone else is tucking into a fourth helping of Christmas dinner. And we know that Wegovy or Mounjaro can be a big financial investment.
So, if you’re going to invest the time, effort, emotion and money - we believe that it’s worth doing properly
Obesity is a lifelong chronic disease affecting some 14 million people in the UK which costs the NHS £6.1 billion per year. It is a debilitating condition associated with a range of comorbidities such as type 2 diabetes, certain cancers, hypertension, heart problems and so on.
The emergence of life-changing medications, Tirzepatide and Wegovy, presents a once-in-a-lifetime opportunity to combat obesity - as clinical trials show weight loss in 16-18 months of 26% and 15% respectively, These belong to a class of drugs called GLP-1 receptor agonists. This is because they mimic the action of glucagon-like peptide-1, a natural hormone in the body which manages hunger. Their primary mechanism revolves around suppressing hunger and promoting a sense of fullness, leading to reduced food intake.
As part of their action, GLP-1 medications slow down the emptying of the stomach, helping individuals to feel satisfied for longer, and they act on the brain to dampen cravings and the desire to eat, creating a dual effect that helps weight loss.
Medications like Mounjaro and Wegovy were never designed to be taken in isolation. Both medicines mimic the hormone that tells us we are full, helping to reduce our food consumption and losing weight over the course of many months (please see our blog on the wider health benefits of weight loss injections by clicking here) But that can have physical and psychological results which need careful management; and simply taking the drug on its own isn’t enough to deliver sustained weight loss. For that, patients need to effect long-term changes in their diet and their approach to physical exercise. All of these elements need to be brought together for the medicines to work effectively.
That’s why CheqUp offers a full weight management service to accompany the medication, consisting of diet support, physical activity advice, psychological counselling where necessary, nurses, health coaches and, of course, specialist obesity doctors. All our interactions are designed and led by experts - with virtual contact facilitated through our web platform.
We encourage all patients to embark on a long-term weight loss journey. The flexible program includes regular virtual appointments with obesity specialists, dieticians, physical activity advisors, nurses, and health coaches. While you’re losing weight, our clinicians constantly assess your progress to provide a comprehensive and individualised approach to weight management. We understand that these medications can bring up a lot of questions, so we encourage all our clients to email us at help@chequp.com with any questions, to arrange check-ins with your health coach or to book an appointment with one of our specialist clinicians.
We believe that this is by far the most effective way to lose weight - it mirrors the way the clinical trials for Mounjaro and Wegovy were structured and the approach the NHS uses in its hospitals. This approach has been proven to get the best out of the medications - to provide initial assistance on how to take weight loss injections, to manage the common side-effects, to help with the dose increase (“titration”) stage. In short - to hold your hand on every step of your journey.
A long-term weight loss programme is an investment of time, effort, emotion and money.
A weight loss journey takes many months, even years, so it is worth spending this time productively and not wasting your precious time on yet another fad diet. We know that dieting takes real effort - it can be really hard to resist the “food noise” and deal with the hunger and the cravings, so make the effort count. Diets can be emotionally draining - we all have bad days when the scales just aren't shifting or everyone else is tucking into a fourth helping of Christmas dinner. And we know that Wegovy or Mounjaro can be a big financial investment.
So, if you’re going to invest the time, effort, emotion and money - we believe that it’s worth doing properly
As seen in
As seen in